COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations, Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference in New York
30/08/2018
DAVIS, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]
Biomerica Announces Fiscal Year End 2018 Financial Results
30/08/2018
IRVINE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the fiscal year 2018 were $5,564,185 versus net sales of $5, [...]
Auris Medical Receives FDA Guidance at Type C Meeting for AM-111 in the Treatment of Sudden Sensorineural Hearing Loss
30/08/2018
Zug, Switzerland, August 30, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental disorders [...]
Allscripts to present at the 2018 Wells Fargo Healthcare Conference
30/08/2018
CHICAGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the 2018 Wells Fargo Healthcare Conference in Boston, MA on Wednesday, [...]
Daré Bioscience, Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference
30/08/2018
Update on recent discussions with the FDA on the Topical 5% Sildenafil Citrate Cream for Female Sexual Arousal Disorder, and on other protofolio programs SAN DIEGO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc [...]
Alder BioPharmaceuticals® to Present at Two Upcoming September Investor Conferences
30/08/2018
BOTHELL, Wash., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Rexahn Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
ROCKVILLE, Md., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]
Caladrius Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
BASKING RIDGE, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Replimune Reports Financial Results for the First Fiscal Quarter, Ended June 30, and Provides Development and Corporate Update
30/08/2018
Completed initial public offering raising $111 million in total gross proceeds Entered into strategic collaboration with Regeneron Pharmaceuticals Signed lease for 63,000 sq. ft. manufacturing facility WOBURN, Mass., [...]
Catalyst Biosciences to Present at H.C. Wainwright & Co. 20th Annual Global Investment Conference
30/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications [...]
IntelGenx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
SAINT LAURENT, Quebec, Aug. 30, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) today announced that its Chief Financial Officer, Andre Godin, is scheduled [...]
Cutera Expands New truSculpt® iD Personalized Body Sculpting Solution to Europe
30/08/2018
BRISBANE, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC. (Nasdaq:CUTR) (“Cutera” or the “Company”), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, today [...]
Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences
30/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced that the company will participate in the following conferences in September: Citi’s 13 th [...]
SunGen Pharma Establishes Injectable Division and Forms Manufacturing Relationship with GRAM
30/08/2018
PRINCETON, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it has entered into [...]
K2M Group Holdings, Inc. Announces Definitive Agreement To Be Acquired by Stryker Corporation
30/08/2018
LEESBURG, Va., Aug. 30, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO) (the “Company” or “K2M”), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional [...]
IRIDEX Cyclo G6™ Laser System for Glaucoma Treatment Used in Majority of Top U.S. Ophthalmology Hospitals
30/08/2018
Recent Study Published by U.S. News and World Report Highlighting the “Best Hospitals for Ophthalmology” Includes 35 IRIDEX Customers MOUNTAIN VIEW, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: [...]
Resverlogix Announces $26 Million Private Placement
30/08/2018
CALGARY, Alberta, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today it has closed a private placement of approximately 10.4 million equity units at a price of [...]
Immune Design to Present at Upcoming September Investor Conferences
30/08/2018
SEATTLE and SOUTH SAN FRANCISCO, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on novel therapies in oncology, today announced that senior management will present at [...]
Pieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
30/08/2018
BOSTON, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for cancer, [...]

Pages